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Dear Editor,
Surface-exposed calreticulin (ecto-CRT) and secreted ATP
have emerged as incontrovertible danger signals.1–3 A surge
in studies describing the impact of these danger signals has
also spurred a tremendous interest in the discovery of
signaling pathways regulating their ‘emission’. Recent
research has shown that the pathways regulating the
emission of these danger signals exhibit a certain degree of
‘plasticity’ and context-dependency.1–4 This applies mainly to
the pathways regulating ecto-CRT emission and ATP
secretion induced by mitoxantrone (MTX)2 and hypericin-
based photodynamic therapy (Hyp-PDT).3–5
Irrespective of the inducers though, molecular components
regulating endoplasmic reticulum (ER)-stress and autophagy
have been found to form the ‘core’ of pathways behind
ecto-CRT and secreted ATP.1,3,5 While ER-stress tends to
regulate these pathways positively,1,3 macroautophagy has
recently emerged to play a more contextual role.1,6 While on
one hand, macroautophagy was found to positively regulate
MTX-induced ATP secretion,2 on the other we found that
macroautophagy negatively regulates Hyp-PDT-induced
ecto-CRT6 (without affecting ATP secretion6). This further
increased our curiosity regarding the role of autophagy
pathways behind ecto-CRT/secreted ATP. Interestingly,
it was recently shown that the lysosomal protein LAMP1 can
regulate MTX-induced ATP secretion.2 We have previously
shown that oxidative stress generated by Hyp-PDT along
with macroautophagy can stimulate chaperone-mediated
autophagy (CMA), a process mediated by the lysosomal
protein, LAMP2A7,8 Cells lacking LAMP2A were found to be
extremely sensitized toward Hyp-PDT-induced apoptotic
cell death, which is mediated by severe reactive oxygen
species-induced ER stress.7 On the back of these exciting
results, we became curious about the impact this
CMA-essential gene can have on cell-surface exposure of
CRT and secretion of ATP.
To this end, we tested the ability of LAMP2Aþ /þ and
LAMP2A / cells to emit secreted ATP/ecto-CRT following
MTX/Hyp-PDT treatments. MTX and Hyp-PDT induced
significant secretion of ATP in LAMP2Aþ /þ cells as com-
pared with the untreated cells (Supplementary Figure S1A).
Similarly, the LAMP2A / cells also retained their capacity to
secrete ATP following MTX/Hyp-PDT treatment, to
the same extent as the LAMP2Aþ /þ cells (Supplementary
Figure S1A).
Next, we analyzed the induction of ecto-CRT and
found both MTX and Hyp-PDT to be potent inducers of ecto-
CRT in the LAMP2Aþ /þ cells (Supplementary Figure S1B),
as expected.4,5 Interestingly, we found that the LAMP2A /
cells exhibited a strong inability to emit ecto-CRT, not only
following MTX/Hyp-PDT treatments but also in basal condi-
tions (Supplementary Figure S1B). This complete abrogation
of ecto-CRT in the absence of LAMP2A indicated an ‘innate’
dysfunction of ecto-CRT trafficking pathway in these cells.
It has been well established that cells lacking LAMP2A exhibit
a compensatory rise in macroautophagy, under basal condi-
tions, to counter the absence of CMA.7,8 We had recently
observed that ablation of macroautophagy (via ATG5-siRNA)
increased Hyp-PDT-induced ecto-CRT.6 Thus, we wondered
whether we can rescue ecto-CRT emission in LAMP2A /
cells if we knockdown ATG5 (ATG5KD). ATG5KD in LAMP2Aþ /þ
cells (Supplementary Figure S1C, left) further increased the
induction of ecto-CRT after treatment (as compared
with LAMP2Aþ /þ cells transfected with Scr-siRNA)
(Supplementary Figure S1C, right), especially after Hyp-
PDT, as expected.6 Contrary to expectations though,
ATG5KD in LAMP2A / cells (B50%KD; Supplementary
Figure S1C, left) failed to re-establish ecto-CRT, both under
basal and treated conditions (Supplementary Figure S1C, right).
These results indicate that possibly the absence of
CMA in LAMP2A / cells underlies their inability to emit
ecto-CRT (rather than compensatory rise in ATG5-regulated
macroautophagy) – a premise that needs to be comprehensively
investigated.
In conclusion, we found that LAMP2A is dispensable
for both MTX and Hyp-PDT-induced ATP secretion. However
interestingly, we observed that the absence of LAMP2A
abrogates ecto-CRT emission (in basal and MTX/Hyp-PDT
treatment scenarios) – a dysfunction that cannot be rescued
by siRNA-based knock-down of ATG5. In future, it would be
imperative to investigate whether there is a direct link between
ecto-CRT emission and CMA induction.
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